The 2024 Global Pharmaceutical Market Products and Trends Conference received a great success: revealing insights and opportunities in the Chinese API, Ethiopian market, and CDMO industries.

Shanghai, May 16, 2024 - On the second day of the API China exhibition, the 2024 Overseas Pharmaceutical Market Products and Trends Conference, jointly organized by ECHEMI and API China, was successfully held this morning in Conference Room M102 at the Shanghai National Exhibition and Convention Center. ECHEMI also conducted a dual live stream through WeChat and LinkedIn platforms, attracting tens of thousands of viewers who actively engaged by leaving comments and asking questions. The Conference received enthusiastic praise and recognition from the audience. The event aimed to provide participants with an opportunity to gain in-depth understanding of the overseas pharmaceutical market and explore the latest products and trends in the industry.

The Conference featured a compact and rich agenda, covering several important topics in the pharmaceutical industry. After the opening remarks, three guest speakers delivered speeches on topics including the export overview and development prospects of Chinese active pharmaceutical ingredients (APIs), analysis of the pharmaceutical market and regulatory requirements in Ethiopia, and the CDMO (Contract Development and Manufacturing Organization) industry in the capital winter. Their speeches provided attendees with valuable industry insights.

Ms. Bree Wang, Vice President and General Manager of the Pharmaceutical Business Unit at ECHEMI, has 15 years of extensive experience in overseas market distribution. During the Conference, she analyzed the export data of pharmaceuticals and APIs in early 2024 and shared the development prospects of the Chinese API industry, as well as its industrial strengths and weaknesses. She also highlighted the risks and challenges faced by the Chinese API export market.

Furthermore, Ms. Bree Wang provided an outlook on the development trends of the Chinese API industry and proposed key directions for its growth. She emphasized the importance of developing distinctive APIs to enhance the competitiveness of Chinese APIs in the international market. She also stressed the significance of innovation in the API category, encouraging the industry to pursue more research and development innovations. Additionally, she mentioned the potential of expanding the CDMO business model, which would bring more business opportunities and possibilities for collaboration to the Chinese API industry. Finally, she put forward the concept of promoting the integration of APIs and formulations, believing that integrating the production chain can improve efficiency and drive industry transformation and upgrading.

Ms. Bree Wang's speech provided attendees with an in-depth understanding of the development of the Chinese API industry and inspired them to seek future business opportunities and directions. Her insights emphasized the importance of innovation, collaboration, and transformation, which are crucial for driving the sustainable development of the Chinese API industry.

Mr. Shimelis Birhanu, the second guest speaker, is the General Manager of Ultra-Med Healthcare Consulting Services. He has years of experience in sales and marketing management in multinational trading companies and generic pharmaceutical companies. At the Conference, he provided attendees with an in-depth understanding of the Ethiopian pharmaceutical market.

Mr. Shimelis Birhanu presented detailed information about the supplier admission process, market size, and local manufacturers in the Ethiopian pharmaceutical market. He offered an overview of the African market to give attendees insights into the potential and opportunities in the region's pharmaceutical market. He also shared trends in the Ethiopian pharmaceutical market, helping attendees gain a deeper understanding of this promising market.

Through Mr. Shimelis Birhanu's speech, attendees gained insights into the current state and future prospects of the Ethiopian pharmaceutical market. His experience and insights provided valuable information and guidance for attendees looking to expand their business in that market. Understanding the trends and scale of the Ethiopian pharmaceutical market will help companies seeking to explore overseas markets develop strategies that align with local demands and seize market opportunities.

The final guest speaker, Mr. Helton Chang, is the CEO of GenoCorp, and he possesses extensive experience in the industry, having held multiple significant positions. In his speech, he delved into the challenges faced by the CDMO (Contract Development and Manufacturing Organization) industry during the capital winter and provided a thorough analysis of the business logic in the industry.

Mr. Helton Chang shared the business model of the CDMO industry and elaborated on how to achieve business growth and long-term success through providing high-quality services, continuous innovation, and establishing close collaborations with customers. He emphasized the importance of delivering excellent service quality and delivery capabilities in a competitive market environment. He also underscored the necessity of continuous innovation, including adopting new technologies and processes, as well as enhancing research and development and production capabilities to meet the evolving needs of customers. Furthermore, he highlighted the significance of establishing close collaborations with customers, understanding their needs and goals deeply, and providing personalized solutions to earn their trust and cooperation.

Mr. Helton Chang's speech provided attendees with a comprehensive understanding of the CDMO industry and helped them comprehend the challenges and opportunities that the industry faces during the capital winter. His experience and insights offered key elements for achieving success in this competitive field. For businesses seeking growth and development in the CDMO sector, his speech provided valuable guidance and inspiration to help them formulate strategies, enhance competitiveness, and stand out in the market.

The successful organization of this Conference provided attendees with a valuable opportunity for learning and exchange, enabling them to gain in-depth knowledge about the development of the Chinese API industry, the potential of the Ethiopian pharmaceutical market, and the business logic of the CDMO industry. Participants actively engaged through the live streaming platforms, raising numerous insightful questions and sharing their perspectives, demonstrating their interest and enthusiasm for these topics. The success of this Conference not only showcased ECHEMI's leadership position and professional competence but also established a broad and in-depth communication platform for industry development and collaboration. It is believed that through the inspiration and exchange from this Conference, attendees will achieve greater accomplishments in their respective fields and make further contributions to the progress and advancement of the industry.